🔗 Permalink

Inventor profile of:

Patrick L. Iversen

City:

Corvallis, Oregon

Country:

United States

Published Applications:

107

Last publication date:

2021-05-13

Top Assignees for applications by Patrick L. Iversen

The entities that hold a legal rights for patent applications filed by inventor Iversen Patrick L.:

AVI BIOPHARMA, INC. 50 Corvallis, OR United States
Sarepta Therapeutics, Inc. 25 Corvallis, OR United States
Sarepta Therapeutics, Inc. 12 Cambridge, MA United States
SAREPTA THERAPEUTICS, INC. 2 BOTHELL, WA United States
U.S. ARMY MEDICAL RESEARCH AND MATERIAL COMMAND 2 FREDERICK, MD United States
OREGON STATE UNIVERSITY 1 Corvallis, OR United States
The United States of America as represented by the Army Medical Research and Material Command 1 Washington, DC United States
Centenary Institute 1 Newtown, Australia
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA 1 Lincoln, NE United States
AVI Bio Pharma, Inc. 1 Corvallis, OR United States
The Scripps Research Institute 1 La Jolla, CA United States
UNIVERSITY OF KANSAS MEDICAL CENTER 1 Kansas City, KS United States
The United States of America as Represented by the Department of Health and Human Services 1 Washington, DC United States
M.I.T. 1 Cambridge, MA United States

Recent patent applications by Iversen Patrick L.

Patrick L. Iversen from Corvallis, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-05-13

US20210139911A1

Chemistry; metallurgy

ANTISENSE COMPOSITION AND METHOD FOR TREATING MUSCLE ATROPHY

#2 | 2020-01-16

US20200016280A1

Human necessities

Compositions for enhancing transport of molecules into cells

#3 | 2019-08-08

US20190241890A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR MANIPULATING TRANSLATION OF PROTEIN ISOFORMS FROM ALTERNATIVE INITIATION START SITES

#4 | 2019-06-06

US20190169611A1

Chemistry; metallurgy

DsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups

#5 | 2018-11-15

US20180327749A1

Chemistry; metallurgy

Antisense composition and method for treating muscle atrophy

#6 | 2018-09-13

US20180258433A1

Chemistry; metallurgy

Renal selective inhibition of cytochrome P450 3A5

#7 | 2018-08-23

US20180237773A1

Chemistry; metallurgy

Splice-region antisense composition and method

#8 | 2017-12-28

US20170368203A1

Human necessities

Compositions for enhancing transport of molecules into cells

#9 | 2017-10-26

US20170306323A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#10 | 2017-08-31

US20170247410A1

Chemistry; metallurgy

Antibacterial antisense oligonucleotide and method

#11 | 2017-06-08

US20170159050A1

Chemistry; metallurgy

SPLICE-REGION ANTISENSE COMPOSITION AND METHOD

#12 | 2016-09-29

US20160281092A1

Chemistry; metallurgy

Antisense composition and method for treating muscle atrophy

#13 | 2016-09-01

US20160251398A1

Chemistry; metallurgy

Antibacterial antisense oligonucleotide and method

#14 | 2015-12-24

US20150368653A1

Chemistry; metallurgy

ANTISENSE MODULATION OF NUCLEAR HORMONE RECEPTORS

#15 | 2015-10-01

US20150275204A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#16 | 2015-09-24

US20150267202A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating ss/RNA viral infection

#17 | 2015-08-20

US20150232839A1

Chemistry; metallurgy

Splice-region antisense composition and method

#18 | 2015-07-02

US20150184165A1

Chemistry; metallurgy

Immunosuppression compound and treatment method

#19 | 2015-05-07

US20150126722A1

Chemistry; metallurgy

OLIGONUCLEOTIDE COMPOUND AND METHOD FOR TREATING NIDOVIRUS INFECTIONS

#20 | 2015-04-30

US20150119316A1

Chemistry; metallurgy

ANTISENSE COMPOSITION AND METHOD FOR TREATING MUSCLE ATROPHY

#21 | 2015-02-05

US20150038462A1

Chemistry; metallurgy

Oligonucleotide analog and method for treating flavivirus infections

#22 | 2014-10-09

US20140303073A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating influenza viral infection

#23 | 2014-10-02

US20140296321A1

Chemistry; metallurgy

Methods and compositions for manipulating translation of protein isoforms from alternative initiation of start sites

#24 | 2014-09-25

US20140287983A1

Chemistry; metallurgy

ANTISENSE COMPOSITIONS AND METHODS FOR MODULATING CONTACT HYPERSENSITIVITY OR CONTACT DERMATITIS

#25 | 2014-07-31

US20140213737A1

Chemistry; metallurgy

Antibacterial antisense oligonucleotide and method

#26 | 2014-07-10

US20140194612A1

Chemistry; metallurgy

Immunosuppression compound and treatment method

#27 | 2014-02-13

US20140045916A1

Chemistry; metallurgy

Splice-region antisense composition and method

#28 | 2014-02-13

US20140044750A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#29 | 2013-10-31

US20130289091A1

Chemistry; metallurgy

Antisense antibacterial method and compound

#30 | 2013-10-31

US20130288369A1

Chemistry; metallurgy

dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups

#31 | 2013-05-23

US20130131312A1

Chemistry; metallurgy

Peptide conjugated, inosine-substituted antisense oligomer compound and method

#32 | 2013-01-10

US20130011420A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#33 | 2012-12-20

US20120322847A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating ssRNA viral infection

#34 | 2012-05-17

US20120122769A1

Chemistry; metallurgy

ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS

#35 | 2012-03-01

US20120053228A1

Chemistry; metallurgy

Splice-region antisense composition and method

#36 | 2012-02-09

US20120035136A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#37 | 2012-02-02

US20120027791A1

Human necessities

ANTISENSE COMPOUND FOR INDUCING IMMUNOLOGICAL TOLERANCE

#38 | 2011-12-29

US20110318382A1

Chemistry; metallurgy

IMMUNOMODULATORY AGENTS AND METHODS OF USE

#39 | 2011-11-24

US20110289608A1

Human necessities

Antisense modulation of interleukins 17 and 23 signaling

#40 | 2011-09-15

US20110224283A1

Chemistry; metallurgy

Antisense modulation of nuclear hormone receptors

#41 | 2011-07-14

US20110172418A1

Chemistry; metallurgy

ANTISENSE RESTENOSIS COMPOSITION AND METHOD

#42 | 2011-07-07

US20110166082A1

Chemistry; metallurgy

Antisense composition and method for treating muscle atrophy

#43 | 2011-05-19

US20110118334A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating influenza viral infection

#44 | 2010-11-18

US20100292189A1

Chemistry; metallurgy

Oligonucleotide analog and method for treating flavivirus infections

#45 | 2010-09-16

US20100234281A1

Chemistry; metallurgy

Antibacterial antisense oligonucleotide and method

#46 | 2010-09-16

US20100234280A1

Human necessities

ANTISENSE ANTIBACTERIAL METHOD AND COMPOUND

#47 | 2010-07-22

US20100184670A1

Chemistry; metallurgy

Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis

#48 | 2010-07-13

US10190419

Delivery of microparticle-conjugated drugs for inhibition of stenosis

#49 | 2010-06-03

US20100137408A1

Chemistry; metallurgy

ANTISENSE ANTIBACTERIAL METHOD AND COMPOUND

#50 | 2010-03-25

US20100074927A1

Human necessities

DELIVERY OF THERAPEUTIC COMPOUNDS VIA MICROPARTICLES OR MICROBUBBLES

#51 | 2010-03-11

US20100063133A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating arenavirus infection

#52 | 2009-10-01

US20090246221A1

Chemistry; metallurgy

Immunomodulatory agents and methods of use

#53 | 2009-07-23

US20090186849A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#54 | 2009-07-23

US20090186848A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#55 | 2009-07-23

US20090186847A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#56 | 2009-04-30

US20090111977A1

Human necessities

Antisense compound for inducing immunological tolerance

#57 | 2009-04-30

US20090110689A1

Chemistry; metallurgy

Immunosuppression compound and treatment method

#58 | 2009-04-16

US20090099066A1

Chemistry; metallurgy

Tissue specific peptide conjugates and methods

#59 | 2009-03-26

US20090082547A1

Human necessities

Compositions for enhancing transport of molecules into cells

#60 | 2009-01-08

US20090012280A1

Chemistry; metallurgy

Oligonucleotide compound and method for treating nidovirus infections

#61 | 2008-12-23

US10836804

Compositions for enhancing transport of molecules into cells

#62 | 2008-12-18

US20080311556A1

Chemistry; metallurgy

Sense Antiviral Compound and Method for Treating Ssrna Viral Infection

#63 | 2008-08-21

US20080199961A1

Chemistry; metallurgy

ANTISENSE COMPOSITION AND METHOD FOR INHIBITION OF miRNA BIOGENESIS

#64 | 2008-08-14

US20080194463A1

Chemistry; metallurgy

Antibacterial antisense oligonucleotide and method

#65 | 2008-08-07

US20080187993A1

Human necessities

METHOD AND ANTISENSE COMPOSITION FOR SELECTIVE INHIBITION OF HIV INFECTION IN HEMATOPOIETIC CELLS

#66 | 2008-07-31

US20080182973A1

Chemistry; metallurgy

Peptide conjugated, inosine-substituted antisense oligomer compound and method

#67 | 2007-11-29

US20070274957A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating arenavirus infection

#68 | 2007-11-15

US20070265215A1

Chemistry; metallurgy

Antisense restenosis composition and method

#69 | 2007-11-15

US20070265214A1

Human necessities

Antisense antiviral agent and method for treating ssRNA viral infection

#70 | 2007-07-03

US10719633

Antisense antibacterial method and composition

#71 | 2007-06-14

US20070135333A1

Human necessities

Antisense antibacterial method and compound

#72 | 2007-06-07

US20070129323A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating picornavirus infection

#73 | 2007-05-31

US20070122821A1

Chemistry; metallurgy

Antisense composition and method for treating muscle atrophy

#74 | 2007-05-17

US20070111962A1

Chemistry; metallurgy

Immunosuppression compound and treatment method

#75 | 2007-04-03

US10668448

Compositions and methods for altering the biodistribution of biological agents

#76 | 2007-03-22

US20070066556A1

Human necessities

Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds

#77 | 2007-03-01

US20070049542A1

Chemistry; metallurgy

Antisense antibacterial method and compound

#78 | 2007-02-15

US20070037764A1

Human necessities

Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells

#79 | 2007-02-15

US20070037763A1

Chemistry; metallurgy

Oligonucleotide compound and method for treating nidovirus infections

#80 | 2007-01-25

US20070021362A1

Chemistry; metallurgy

Antisense antibacterial method and compound

#81 | 2007-01-04

US20070004661A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating influenza viral infection

#82 | 2006-12-28

US20060293268A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating foot and mouth disease

#83 | 2006-12-21

US20060287268A1

Chemistry; metallurgy

Splice-region antisense composition and method

#84 | 2006-12-14

US20060281701A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#85 | 2006-12-07

US20060276425A1

Human necessities

Antisense oligomers and methods for inducing immune tolerance and immunosuppression

#86 | 2006-11-30

US20060269911A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating ssRNA viral infection

#87 | 2006-11-30

US20060269587A1

Human necessities

Antisense restenosis composition and method

#88 | 2006-10-26

US20060240032A1

Human necessities

Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases

#89 | 2006-10-03

US10355388

Microbubble compositions and methods for oligonucleotide delivery

#90 | 2006-09-14

US20060205693A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#91 | 2006-08-22

US9493427

Antisense restenosis composition and method

#92 | 2006-07-06

US20060148747A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating influenza viral infection

#93 | 2006-06-08

US20060121010A1

Human necessities

Chorionic gonadotropin DNA vaccines and methods

#94 | 2006-03-23

US20060063150A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating ssRNA viral infection

#95 | 2005-12-29

US20050288246A1

Chemistry; metallurgy

Peptide conjugated, inosine-substituted antisense oligomer compound and method

#96 | 2005-11-24

US20050261249A1

Human necessities

Antisense composition and method for treating cancer

#97 | 2005-10-20

US20050234002A1

Human necessities

Antisense oligomers and methods for inducing immune tolerance and immunosuppression

#98 | 2005-10-06

US20050222068A1

Human necessities

Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells

#99 | 2005-09-15

US20050203041A1

Chemistry; metallurgy

Antisense compound and method for selectively killing activated T cells

#100 | 2005-09-01

US20050192237A1

Chemistry; metallurgy

Antisense antibacterial cell division composition and method

InventorID:

27120 ⎘